Sign in

CIK 0001061983

  • Large accelerated filer

CYTOKINETICS INC

Sign in to watch
Ticker
CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
943291317
Phone
+1 650-624-3000
Business address
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Shares withheld for taxes President & CEO gave up 5,930 shares (to pay taxes)
  2. 4 Planned sale Director sold 8,750 shares at $63.90 ($559,125)
  3. 4 Planned sale EVP Research & Development sold 2,200 shares at $63.89 ($140,558)
  4. 4 Planned sale Director sold 28,064 shares at $66.72 ($1,872,430)
  5. 4 Planned sale Director sold 2,150 shares at $66.80 ($143,620)
  6. 4 Planned sale Director sold 5,000 shares at $64.73 ($323,650)
  7. 4 Planned sale EVP Research & Development sold 2,200 shares at $66.45 ($146,190)
  8. 4 Grant or award Chief Legal & Admin Officer acquired 87,297 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Planned sale Director sold 5,175 shares at $65.08 ($336,789)
  11. 4 Gift President & CEO gave 2,000 shares (gift)
  12. 4 Planned sale EVP Research & Development sold 2,295 shares at $59.55 ($136,667)
  13. 4 Planned sale President & CEO sold 5,000 shares at $62.86 ($314,300)
  14. 4 Planned sale Director sold 4,375 shares at $58.68 ($256,725)
  15. 4 Planned sale EVP Research & Development sold 2,105 shares at $58.22 ($122,553)
  16. 4 Grant or award Director acquired 99 shares (grant or award)
  17. 4 Planned sale President & CEO sold 5,000 shares at $60.03 ($300,150)
  18. 4 Grant or award Director acquired 199 shares (grant or award)
  19. 4 Grant or award Director acquired 338 shares (grant or award)
  20. 4 Grant or award Director acquired 199 shares (grant or award)

Page 7 of 70 · 1,399 filings